1/3/2019 8:02:03 AM
Inovio Names Simon Benito Chairman; Avtar Dhillon Is Retiring
11/15/2018 8:03:03 AM
Inovio Adds Rafi Ahmed To Scientific Advisory Board; Laurent Humeau Named Chief Scientific Officer
11/8/2018 4:10:49 PM
Inovio Pharmaceuticals Q3 Loss/share $0.27 Vs. Loss $0.40 Year Ago
10/22/2018 8:05:11 AM
Inovio Presents PFS & PSA Doubling Time Improvements In Prostate Cancer Patients Treated With INO-5150
10/15/2018 8:02:53 AM
Inovio Says Its Ebola Vaccine Provides 100% Protection And Elicits Long-Lasting Immune Responses In Preclinical Studies
10/8/2018 8:03:10 AM
Inovio Develops First DNA-Encoded Monoclonal Antibody Checkpoint Inhibitor And Demonstrates Tumor Shrinkage
10/2/2018 8:15:27 AM
Inovio Reports Major Cancer Journal Highlights Data From An Inovio-Sponsored Trial
9/17/2018 8:30:05 AM
Inovio Pharma Develops Novel H3N2 Influenza DNA Vaccine; Provides Complete Protection Against Lethal Challenges
9/5/2018 8:01:37 AM
Inovio Doses 1st Subject In Phase 1/2 Clinical Trial For Vaccine Against Deadly MERS Infection
9/4/2018 1:03:20 AM
Inovio, GeneOne Dose First Patient In Phase 1 Study To Evaluate Preventive Vaccine Against Hepatitis C Infection
8/16/2018 8:02:27 AM
Inovio Doses First Patient In Phase 1/2a Study Designed To Evaluate INO-5401
8/14/2018 8:04:17 AM
Inovio Says First Participant Dosed With PENNVAX-GP In Randomized Clinical Trial
8/7/2018 4:08:28 PM
Inovio Q2 Net Loss $6.6 Mln Or $0.08 Per Share
8/6/2018 8:06:29 AM
Inovio Enters Partnership With AIDS Malignancy Consortium To Evaluate VGX-3100